Cypress rejects Ramius offer again

The board of Cypress Bioscience Inc. (NASDAQ:CYPB) rejected an unsolicited offer for the

Read the full 133 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE